Login to Your Account



Depomed Preparing NDA With Positive Ciprofloxacin GR Data

By Karen Pihl-Carey


Friday, March 19, 2004
Depomed Inc.'s new formulation of ciprofloxacin HCl achieved top-notch results in a Phase III trial of urinary tract infections. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription